Nanoscale Horiz., 2025, Accepted Manuscript
DOI: 10.1039/D4NH00652F, Communication
DOI: 10.1039/D4NH00652F, Communication
LIN LI, Pengyao Wei, Tong Kong, Bo Yuan, Pan Fu, Yong Li, Yuhui Wang, Jianping Zheng, Kaizhe Wang
Triple-negative breast cancer (TNBC) is highly invasive with a poor prognosis, and chemotherapy remains the clinical treatment of choice. Paclitaxel is a commonly used first-line chemotherapy drug, but its untargeted...
The content of this RSS Feed (c) The Royal Society of Chemistry
Triple-negative breast cancer (TNBC) is highly invasive with a poor prognosis, and chemotherapy remains the clinical treatment of choice. Paclitaxel is a commonly used first-line chemotherapy drug, but its untargeted...
The content of this RSS Feed (c) The Royal Society of Chemistry
